VG2062

· Shanghai Virogin Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VG2062, covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors [Phase 1]

See pricing